In vitro and in vivo anticalcification effects of novel bishydroxyiminophosphonates
- PMID: 1432609
- DOI: 10.1002/jps.2600811009
In vitro and in vivo anticalcification effects of novel bishydroxyiminophosphonates
Abstract
Some geminal bisphosphonates are used clinically for a number of important bone- and/or calcium-related diseases; however, side effects and lack of selectivity impede their wide use. This work reports the synthesis and evaluation of bishydroxyiminophosphonates (e.g., adipoyl- and suberoylbisphosphonate dioximes). These compounds significantly inhibited hydroxyapatite formation and dissolution in vitro and the calcification of bioprosthetic tissue implanted subdermally in rats. The compounds reported in this paper are less active than the structurally related bisacylphosphonates. The results of this work indicate that the introduction of oxime groups adjacent to the phosphonic function in long-chain bisphosphonates confers calcium interaction capabilities and that complete ionizability of a bisphosphonate may enhance its biological activity.
Similar articles
-
Bisacylphosphonates inhibit hydroxyapatite formation and dissolution in vitro and dystrophic calcification in vivo.Pharm Res. 1992 Jan;9(1):143-8. doi: 10.1023/a:1018956516640. Pharm Res. 1992. PMID: 1589400
-
Anticalcification and antiresorption effects of bisacylphosphonates.Bone. 1995 May;16(5):511-20. doi: 10.1016/8756-3282(95)00081-n. Bone. 1995. PMID: 7654466
-
In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.J Pharm Sci. 1997 Mar;86(3):283-9. doi: 10.1021/js960429h. J Pharm Sci. 1997. PMID: 9050794
-
Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.Recent Results Cancer Res. 1989;116:1-28. doi: 10.1007/978-3-642-83668-8_1. Recent Results Cancer Res. 1989. PMID: 2669065 Review.
-
Experimental basis for the use of bisphosphonates in Paget's disease of bone.Clin Orthop Relat Res. 1987 Apr;(217):72-8. Clin Orthop Relat Res. 1987. PMID: 3549097 Review.
Cited by
-
Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders.Pharm Res. 1998 Apr;15(4):606-13. doi: 10.1023/a:1011990129437. Pharm Res. 1998. PMID: 9587958
-
In vitro inhibition of membrane-mediated calcification by novel phosphonates.Calcif Tissue Int. 1996 May;58(5):347-54. doi: 10.1007/BF02509384. Calcif Tissue Int. 1996. PMID: 8661970
-
Clodronate: a review of its use in breast cancer.Drugs Aging. 1999 Aug;15(2):143-67. doi: 10.2165/00002512-199915020-00007. Drugs Aging. 1999. PMID: 10495073 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources